Sarayut Sompim

Person

Born

1997-03-23

via Open Library + Wikidata

Recent publications · Crossref

5 total works indexed

1. Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations

   · 2013 · cited 2,653x

2. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

   · 2014 · cited 1,611x

3. Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

   · 2020 · cited 1,432x

4. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

   · 2015 · cited 1,286x

5. First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study